Holen Sie sich die Stockscreener-App
2.90
0.00%
0.00
Vorhandelsmarkt:
2.76
-0.14
-4.83%
Schlusskurs vom Vortag:
$2.90
Offen:
$2.85
24-Stunden-Volumen:
155.53K
Relative Volume:
0.94
Marktkapitalisierung:
$2.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.27M
KGV:
-0.1354
EPS:
-21.4132
Netto-Cashflow:
$-9.40M
1W Leistung:
-3.65%
1M Leistung:
-10.05%
6M Leistung:
-61.33%
1J Leistung:
-78.83%
1-Tages-Spanne:
$2.72
$2.98
1-Wochen-Bereich:
$2.34
$2.98
52-Wochen-Spanne:
$2.34
$23.70
Dermata Therapeutics Inc Stock (DRMA) Company Profile
Firmenname
Dermata Therapeutics Inc
Sektor
Branche
Telefon
(858)-223-0882
Adresse
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Vergleichen Sie DRMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
2.90 | 2.98M | 0 | -11.27M | -9.40M | -21.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Dermata Therapeutics Inc Aktie (DRMA) Neueste Nachrichten
Check Out Dermata Therapeutics Inc (DRMA)’s Trade Data Rather Than the Analysts’ Views - Setenews
Aug Weekly: What technical signals suggest for IKNA stockMarket Risk Report & Scalable Portfolio Growth Methods - BỘ NỘI VỤ
Dermata Therapeutics, Inc. (DRMA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Is Dermata Therapeutics Inc. Equity Warrant stock a buy on dipsBreakout Watch & Risk Adjusted Swing Trade Ideas - Newser
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
DRMAWDermata Therapeutics Inc Latest Stock News & Market Updates - Stock Titan
A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity - ACCESS Newswire
Dermata Therapeutics (NASDAQ: DRMA) teases OTC brand, plans 2026 acne kit launch - Stock Titan
Is Dermata Therapeutics Inc Equity Warrant a good long term investmentVolatility Trading Techniques & Stay Ahead With Daily Market Discussions - earlytimes.in
Dermata Therapeutics (DRMA) Stock Analysis Report | Financials & Insights - Benzinga
Returns Recap: Will Dermata Therapeutics Inc. stock see insider buyingWeekly Trade Review & Detailed Earnings Play Strategies - BỘ NỘI VỤ
Is Dermata Therapeutics Inc. stock a contrarian buyJuly 2025 Reactions & Entry Point Confirmation Signals - moha.gov.vn
Dermata Therapeutics Inc files for mixed shelf of up to $100 million - marketscreener.com
Dermata Therapeutics, Inc.Warrant (NQ: DRMAW - Markets Financial Content
What momentum indicators show for Dermata Therapeutics Inc. Equity Warrant stockStock Surge & Real-Time Market Sentiment Alerts - newser.com
Can Dermata Therapeutics Inc. stock deliver surprise earnings beatJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - newser.com
Dermata Therapeutics Ends License Agreement with Villani - MSN
Can Dermata Therapeutics Inc. Equity Warrant stock sustain market leadershipTrend Reversal & Trade Opportunity Analysis - newser.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Statistical indicators supporting Dermata Therapeutics Inc.’s strengthEarnings Overview Summary & Real-Time Market Sentiment Reports - newser.com
Is Dermata Therapeutics Inc. Equity Warrant stock a safe investment in uncertain marketsWeekly Trading Summary & Weekly High Potential Stock Alerts - newser.com
Is Dermata Therapeutics Inc. Equity Warrant stock vulnerable to regulatory risksJuly 2025 Catalysts & Free Safe Entry Trade Signal Reports - newser.com
Why Dermata Therapeutics Inc. stock could see breakout soonWeekly Investment Summary & Stock Market Timing Techniques - newser.com
Can Dermata Therapeutics Inc. stock sustain market leadershipJuly 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - newser.com
How to manage a losing position in Dermata Therapeutics Inc.July 2025 Market Mood & Weekly Setup with High ROI Potential - newser.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Will Dermata Therapeutics Inc. stock benefit from green energy trendsQuarterly Profit Review & Low Drawdown Investment Ideas - newser.com
How to use Fibonacci retracement on Dermata Therapeutics Inc.Dollar Strength & Real-Time Buy Signal Alerts - newser.com
Can Dermata Therapeutics Inc. Equity Warrant stock resist market sell offsJuly 2025 Price Swings & Breakout Confirmation Alerts - newser.com
Is Dermata Therapeutics Inc. Equity Warrant building a consolidation base2025 Fundamental Recap & Short-Term High Return Strategies - newser.com
Has Dermata Therapeutics Inc. formed a bullish divergenceMarket Activity Summary & Daily Entry Point Trade Alerts - newser.com
Dermata Therapeutics Incon Nov 17, Termina - 富途牛牛
Visualizing Dermata Therapeutics Inc. stock with heatmapsShare Buyback & Step-by-Step Trade Execution Guides - newser.com
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results - Chronicle-Tribune
Finanzdaten der Dermata Therapeutics Inc-Aktie (DRMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):